The British Medicines Regulator has approved AstraZeneca’s antibody treatment for COVID-19 for immunocompromised adults, a major step in the fight against the pandemic as infections rise worldwide amid the rise of the Omicron variant.

4gi.tv
The British Medicines Regulator has approved AstraZeneca’s antibody treatment for COVID-19 for immunocompromised adults, a major step in the fight against the pandemic as infections rise worldwide amid the rise of the Omicron variant.
Copyright © 2022. All Rights Reserved.